2018/19 Annual Report
BoMRA Press Release MED Safety Week
The Botswana Medicines Regulatory Authority (BoMRA) is a new authority that is set up under the Medicines and Related Substances Act (MRSA) of 2013 and was established by the Botswana Government to regulate the supply chain of medicines and related substances, cosmetics and medical devices in order to ensure their quality, safety and efficacy. https://bomra.developer.co.bw/wp-content/uploads/2022/07/capsule-pill.webp
Tender Notice Addendum
TENDER ENQUIRY NO.: MRA-HDOC-009.0 – 2021/2022 PROVISION OF EMPLOYEE WELLNESS SERVICES FOR A PERIOD OF THREE(3) YEARS The tender is amended as follows: 1. Additional PPADB Code: the tender is amended to include the following code:Code: 322 – Health Care Consulting ServicesSub code: 02 – Guidance & Counselling2. Extension of Closing date: The tender is further […]
BoMRA Multiple Tenders Notice
BoMRA Medical Devices stakeholder engagement notice
The Botswana Medicines Regulatory Authority (BoMRA) will be conducting virtual stakeholder engagements to discuss the MRS ACT, Medical Devices Regulatory Framework, Medical Devices Exemptions and update on Listing exercise. The roles played by Healthcare Facilities and Procurement Entities in ensuring that safe Medical Devices and IVDs are imported into the country, services availed by BoMRA […]
Public Notice-COVID-19 Related medical Devices Exemptions Requirements
Botswana Medicines Regulatory Authority (BoMRA) would like to inform relevant stake holders that; that all Covid-19 related medical devices and IVDs should go through an exemption process before they can be imported into the country.
BoMRA office closure 2 July 2021
The Botswana Medicines Regulatory Authority would like to advise all our valued stakeholders that our offices will be closed from Friday 02nd July- Monday OSth July 2021.
Expression of Interest- Supplier Database
Grand-Pa Products are not Allowed In Botswana
The Botswana Medicines Regulatory Authority (BoMRA) wishes to inform the public, healthcare practitioners, importers, and distributors that ALL Grand-Pa pain relief products (powder and tablets ) remain suspended from registration and therefore are not allowed in Botswana.
VMP Stakeholder Engagement Postponed
Please be informed that the VET stakeholder engagement that was scheduled for the 14-15 of June 2021 has been postponed to the 12-13 July 2021.